These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 23819327)
1. [Role of circulating angiogenic factors in diabetic kidney disease]. Martynov SA; Shestakova MV; Kutyrina IM; Il'in AV; Arbuzova MI; Dedov II Vestn Ross Akad Med Nauk; 2013; (2):35-42. PubMed ID: 23819327 [TBL] [Abstract][Full Text] [Related]
2. Study of Angiopoietin-2 and vascular endothelial growth factor as markers of diabetic nephropathy onset in Egyptians diabetic patients with non-albuminuric state. Aly MH; Arafat MA; Hussein OA; Elsaid HH; Abdel-Hammed AR Diabetes Metab Syndr; 2019; 13(2):1623-1627. PubMed ID: 31336531 [TBL] [Abstract][Full Text] [Related]
3. Plasma vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in diabetes: implications for cardiovascular risk and effects of multifactorial intervention. Lim HS; Blann AD; Chong AY; Freestone B; Lip GY Diabetes Care; 2004 Dec; 27(12):2918-24. PubMed ID: 15562207 [TBL] [Abstract][Full Text] [Related]
4. Angiopoietin-1 and angiopoietin-2 in diabetes mellitus: relationship to VEGF, glycaemic control, endothelial damage/dysfunction and atherosclerosis. Lim HS; Lip GY; Blann AD Atherosclerosis; 2005 May; 180(1):113-8. PubMed ID: 15823283 [TBL] [Abstract][Full Text] [Related]
5. The association of serum angiogenic growth factors with renal structure and function in patients with adult autosomal dominant polycystic kidney disease. Coban M; Inci A Int Urol Nephrol; 2018 Jul; 50(7):1293-1300. PubMed ID: 29654395 [TBL] [Abstract][Full Text] [Related]
6. Serum angiopoietin-2: a promising biomarker for early diabetic kidney disease in children and adolescents with type 1 diabetes. Salem NA; Ismail WM; Hendawy SR; Abdelrahman AM; El-Refaey AM Eur J Pediatr; 2024 Sep; 183(9):3853-3862. PubMed ID: 38884820 [TBL] [Abstract][Full Text] [Related]
7. Soluble serum Klotho in diabetic nephropathy: relationship to VEGF-A. Kacso IM; Bondor CI; Kacso G Clin Biochem; 2012 Nov; 45(16-17):1415-20. PubMed ID: 22836100 [TBL] [Abstract][Full Text] [Related]
8. Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)]. Nadar SK; Blann A; Beevers DG; Lip GY J Intern Med; 2005 Oct; 258(4):336-43. PubMed ID: 16164572 [TBL] [Abstract][Full Text] [Related]
9. Altered vascular homeostasis in type 2 diabetic nephropathy. Futrakul N; Butthep P; Futrakul P Ren Fail; 2009; 31(3):207-10. PubMed ID: 19288326 [TBL] [Abstract][Full Text] [Related]
10. The impairment of renal function is not associated to altered circulating vascular endothelial growth factor in patients with Type 2 diabetes and hypertension. Cipriani R; Sensi M; Gabriele A; Gatti A; Mandosi E; Di Mario U; Morano S Diabetes Nutr Metab; 2004 Apr; 17(2):90-4. PubMed ID: 15244100 [TBL] [Abstract][Full Text] [Related]
11. Serum and urinary SOD3 in patients with type 2 diabetes: comparison with early chronic kidney disease patients and association with development of diabetic nephropathy. Kuo CW; Chen HL; Tu MY; Chen CM Am J Physiol Renal Physiol; 2019 Jan; 316(1):F32-F41. PubMed ID: 30303710 [TBL] [Abstract][Full Text] [Related]
12. Angiopoietin-2 is associated with albuminuria and microinflammation in chronic kidney disease. Chang FC; Lai TS; Chiang CK; Chen YM; Wu MS; Chu TS; Wu KD; Lin SL PLoS One; 2013; 8(3):e54668. PubMed ID: 23469160 [TBL] [Abstract][Full Text] [Related]